NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|70995422|ref|NP_001020605|]
View 

NAD(P)H dehydrogenase [quinone] 1 isoform c [Homo sapiens]

Protein Classification

NAD(P)H-dependent oxidoreductase( domain architecture ID 10006206)

NAD(P)H-dependent oxidoreductase which catalyzes the reduction or oxidation of a substrate coupled to the oxidation or reduction, respectively, of a nicotinamide adenine dinucleotide cofactor NAD(P)H or NAD(P)+; similar to Escherichia coli NADPH:quinone oxidoreductase MdaB

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
5-178 2.16e-33

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


:

Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 119.17  E-value: 2.16e-33
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 70995422   5 RALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDItgklkdpanfqypaesvlaYKEGHLSPD 84
Cdd:COG2249   1 KILIIYAHPDPSSFNAALAEAAAEGLEAAGHEVTVHDLYAEGFDPVLSAADF-------------------YRDGPLPID 61
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 70995422  85 IVAEQKKLEAADLVIFQS--------------------------------------KKAVLSITTGGSGSMYSLQGIHGD 126
Cdd:COG2249  62 VAAEQELLLWADHLVFQFplwwysmpallkgwidrvltpgfaygygggypggllkgKKALLVVTTGGPEEAYSRLGYGGP 141
                       170       180       190       200       210
                ....*....|....*....|....*....|....*....|....*....|..
gi 70995422 127 MNVILwpiQSGILHFCGFQVLEPQLTYSIGHTPADARIQILEGWKKRLENIW 178
Cdd:COG2249 142 IEELL---FRGTLGYCGMKVLPPFVLYGVDRSSDEERAAWLERVRELLAALA 190
 
Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
5-178 2.16e-33

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 119.17  E-value: 2.16e-33
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 70995422   5 RALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDItgklkdpanfqypaesvlaYKEGHLSPD 84
Cdd:COG2249   1 KILIIYAHPDPSSFNAALAEAAAEGLEAAGHEVTVHDLYAEGFDPVLSAADF-------------------YRDGPLPID 61
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 70995422  85 IVAEQKKLEAADLVIFQS--------------------------------------KKAVLSITTGGSGSMYSLQGIHGD 126
Cdd:COG2249  62 VAAEQELLLWADHLVFQFplwwysmpallkgwidrvltpgfaygygggypggllkgKKALLVVTTGGPEEAYSRLGYGGP 141
                       170       180       190       200       210
                ....*....|....*....|....*....|....*....|....*....|..
gi 70995422 127 MNVILwpiQSGILHFCGFQVLEPQLTYSIGHTPADARIQILEGWKKRLENIW 178
Cdd:COG2249 142 IEELL---FRGTLGYCGMKVLPPFVLYGVDRSSDEERAAWLERVRELLAALA 190
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
5-174 6.95e-22

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 88.93  E-value: 6.95e-22
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 70995422     5 RALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMnFNPIISRKDITGklkdpanfqypaesvLAYKEGhlSPD 84
Cdd:pfam02525   2 KILIINAHPRPGSFSSRLADALVEALKAAGHEVTVRDLYAL-FLPVLDAEDLAD---------------LTYPQG--AAD 63
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 70995422    85 IVAEQKKLEAADLVIFQS---------------------------------------KKAVLSITTGGSGSMYSLQGIHG 125
Cdd:pfam02525  64 VESEQEELLAADVIVFQFplywfsvpallkgwidrvlragfafkyeeggpggggllgKKVLVIVTTGGPEYAYGKGGYNG 143
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|.
gi 70995422   126 -DMNVILWPIQsGILHFCGFQVLEPQLTYSI-GHTPADARIQILEGWKKRL 174
Cdd:pfam02525 144 fSLDELLPYLR-GILGFCGITDLPPFAVEGTaGPEDEAALAEALERYEERL 193
 
Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
5-178 2.16e-33

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 119.17  E-value: 2.16e-33
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 70995422   5 RALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDItgklkdpanfqypaesvlaYKEGHLSPD 84
Cdd:COG2249   1 KILIIYAHPDPSSFNAALAEAAAEGLEAAGHEVTVHDLYAEGFDPVLSAADF-------------------YRDGPLPID 61
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 70995422  85 IVAEQKKLEAADLVIFQS--------------------------------------KKAVLSITTGGSGSMYSLQGIHGD 126
Cdd:COG2249  62 VAAEQELLLWADHLVFQFplwwysmpallkgwidrvltpgfaygygggypggllkgKKALLVVTTGGPEEAYSRLGYGGP 141
                       170       180       190       200       210
                ....*....|....*....|....*....|....*....|....*....|..
gi 70995422 127 MNVILwpiQSGILHFCGFQVLEPQLTYSIGHTPADARIQILEGWKKRLENIW 178
Cdd:COG2249 142 IEELL---FRGTLGYCGMKVLPPFVLYGVDRSSDEERAAWLERVRELLAALA 190
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
5-174 6.95e-22

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 88.93  E-value: 6.95e-22
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 70995422     5 RALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMnFNPIISRKDITGklkdpanfqypaesvLAYKEGhlSPD 84
Cdd:pfam02525   2 KILIINAHPRPGSFSSRLADALVEALKAAGHEVTVRDLYAL-FLPVLDAEDLAD---------------LTYPQG--AAD 63
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 70995422    85 IVAEQKKLEAADLVIFQS---------------------------------------KKAVLSITTGGSGSMYSLQGIHG 125
Cdd:pfam02525  64 VESEQEELLAADVIVFQFplywfsvpallkgwidrvlragfafkyeeggpggggllgKKVLVIVTTGGPEYAYGKGGYNG 143
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|.
gi 70995422   126 -DMNVILWPIQsGILHFCGFQVLEPQLTYSI-GHTPADARIQILEGWKKRL 174
Cdd:pfam02525 144 fSLDELLPYLR-GILGFCGITDLPPFAVEGTaGPEDEAALAEALERYEERL 193
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH